TP53 and cholangiocarcinoma: An analysis carried out among CCA samples of 195 patients showed that in intrahepatic CCA the most commonly seen aberrations were : IDH1 (30%), ARID1A (23%), BAP1 (20%), TP53 (20%), and FGFR2 gene fusions (14%).